NEUROCLIN LIMITED - Profile & Financials

Accounts Submitted 3 Jul 2025

Confirmation Statement Submitted 10 Mar 2025

Net assets £2.87M £1.47M 2024 year on year

Total assets £4.55M £1.53M 2024 year on year

Total Liabilities £1.68M £87.51K 2024 year on year

Charges 5

4 outstanding 1 satisfied

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Excel House 1 Renshaw Place Motherwell ML1 4UF Scotland

Office ()

Motherwell, North Lanarkshire, United Kingdom, Europe

Telephone

0141 948 0206

info@neuroclin.com

Website

neuroclin.com

Credit Report

Discover NEUROCLIN LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2013–2024)

Cash in Bank

£1.42M

Increased by £578.15k (+69%)

Net Assets

£2.87M

Increased by £1.47M (+104%)

Total Liabilities

£1.68M

Increased by £87.51k (+5%)

Turnover

N/A

Employees

Debt Ratio

37%

Decreased by 16 (-30%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

1 active 3 resigned

Show resigned officers

						Status
Fraser George Inglis	Director	British	Scotland	62	10 Feb 2003	Active

Shareholders

Shareholders (1)


Fraser George Inglis	100.0%	10,000	Ordinary	20 Feb 2017

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Glasgow Memory Clinic Holdings Limited

United Kingdom

Active

Notified 20 Nov 2020

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

Fraser George Inglis

Ceased 20 Nov 2020

Ceased

See All Controllers

Group Structure

NEUROCLIN HOLDINGS LIMITED united kingdom significant influence or control

FULLBROOK THORPE INVESTMENTS LLP united kingdom

SCOTTISH GROWTH SCHEME - FORESIGHT GROUP EQUITY FINANCE LP united kingdom part right to share surplus assets 25 to 50 percent, appoint/remove person, voting rights 25 to 50 percent

FORESIGHT GROUP EQUITY FINANCE (SGS) GP LLP united kingdom voting rights 75 to 100 percent limited liability partnership, right to share surplus assets 75 to 100 percent limited liability partnership, appoint/remove members limited liability partnership

FORESIGHT COMPANY 1 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

FORESIGHT GROUP HOLDINGS (UK) LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

FORESIGHT GROUP HOLDINGS LIMITED british channel islands

NEUROCLIN LIMITED Current Company

MEMORYCLINIC.COM LIMITED united kingdom shares 75 to 100 percent

Charges

4 outstanding 1 satisfied

Documents

Company Filings

Date	Category	Description	Document
3 Jul 2025	Accounts	Annual accounts made up to 2024-09-30	View(12 pages)
10 Mar 2025	Confirmation Statement	Confirmation statement made on 2025-02-10 with no updates	View(3 pages)
10 Mar 2025	Confirmation Statement	Second Filing Of Confirmation Statement With Made Up Date	View(3 pages)
10 Mar 2025	Confirmation Statement	Second Filing Of Confirmation Statement With Made Up Date	View(3 pages)
7 Mar 2025	Persons With Significant Control	Change to Glasgow Memory Clinic Holdings Limited as a person with significant control on 2023-11-13	View(2 pages)